Company profile
3io Therapeutics company profile
3io Therapeutics is a Toronto-based biotechnology company focused on the development and commercialisation of the next generation of viral immunotherapies for cancer. 3io is currently developing a novel viral immunotherapy based on bovine herpesvirus type 1 (BHV-1), a virus that naturally infects cattle but is non-pathogenic in humans. 3io is committed to accelerating its development as a new therapeutic platform to improve treatment responses and outcomes for hard-to-treat cancers, including those with KRAS mutations.
Business identity
- Phone number
- 1 (437) 782 6534
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 00001-00010 employees
- Founded
- 2020-01-01
Headquarters
- Headquarters
- Toronto, Ontario, Canada
- Country code
- CA
- Continent
- North America